
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
Shuang Chen, Da Xu, Fan Liu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 14
Open Access | Times Cited: 39
Shuang Chen, Da Xu, Fan Liu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 14
Open Access | Times Cited: 39
Showing 26-50 of 39 citing articles:
Pharmacological Analysis of GABAA Receptor and Sigma1R Chaperone Interaction: Research Report I―Investigation of the Anxiolytic, Anticonvulsant and Hypnotic Effects of Allosteric GABAA Receptors’ Ligands
М. В. Воронин, S. Shangin, С. А. Литвинова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9580-9580
Open Access | Times Cited: 3
М. В. Воронин, S. Shangin, С. А. Литвинова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9580-9580
Open Access | Times Cited: 3
Evaluation of bioactive potentials in the crude flavonoid fraction from the leaves of Butea monosperma in vitro and in vivo in experimental models
Rajni Bala, Sakshi Mehta, Vikas C. Roy, et al.
Indian Journal of Experimental Biology (2023) Vol. 61, Iss. 11
Open Access | Times Cited: 2
Rajni Bala, Sakshi Mehta, Vikas C. Roy, et al.
Indian Journal of Experimental Biology (2023) Vol. 61, Iss. 11
Open Access | Times Cited: 2
An overview about neurological diseases in India – A theranostics approach
Balachandar Vellingiri
Aging and Health Research (2023) Vol. 4, Iss. 1, pp. 100177-100177
Open Access | Times Cited: 2
Balachandar Vellingiri
Aging and Health Research (2023) Vol. 4, Iss. 1, pp. 100177-100177
Open Access | Times Cited: 2
Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection
Lidia Gatto, Vincenzo Di Nunno, Alicia Tosoni, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access
Lidia Gatto, Vincenzo Di Nunno, Alicia Tosoni, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access
Pediatric Epilepsy and its Health Conditions in UAE: A Review Article
Haitham ELsayed Elsadek
Deleted Journal (2024) Vol. 3, Iss. 1, pp. 35-42
Open Access
Haitham ELsayed Elsadek
Deleted Journal (2024) Vol. 3, Iss. 1, pp. 35-42
Open Access
CPEB3 can regulate seizure susceptibility by inhibiting the transcriptional activity of STAT3 on NMDARs expression
Zhipeng You, Cong Huang, Wei Fan, et al.
Research Square (Research Square) (2024)
Closed Access
Zhipeng You, Cong Huang, Wei Fan, et al.
Research Square (Research Square) (2024)
Closed Access
WITHDRAWN: CPEB3 can regulate seizure susceptibility by inhibiting the transcriptional activity of STAT3 on NMDARs expression
Zhipeng You, Cong Huang, Wei Fan, et al.
Research Square (Research Square) (2024)
Closed Access
Zhipeng You, Cong Huang, Wei Fan, et al.
Research Square (Research Square) (2024)
Closed Access
The correlation of GluR3B antibody with T lymphocyte subsets and inflammatory factors and their role in the progression of epilepsy
Qingwei Lai, Nuan Wang, Binbin Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Qingwei Lai, Nuan Wang, Binbin Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models
Roshan Tumdam, Yara Hussein, Tali Garin-Shkolnik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12366-12366
Open Access
Roshan Tumdam, Yara Hussein, Tali Garin-Shkolnik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12366-12366
Open Access
Memantine-Assisted Treatment of N-Methyl-D-Aspartate Receptor Antibody Encephalitis: A Mini Review
Fei-xiang Liu, Qi Qiu, Yan Feng, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2457-2464
Open Access
Fei-xiang Liu, Qi Qiu, Yan Feng, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2457-2464
Open Access
Exploration of the potential neuroprotective compounds targeting GluN1-GluN2B NMDA receptors
Meixi He, Yi Wang, Xiaozhe Zhang, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 20, pp. 10900-10908
Closed Access | Times Cited: 1
Meixi He, Yi Wang, Xiaozhe Zhang, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 20, pp. 10900-10908
Closed Access | Times Cited: 1
Socrates: A Novel N-Ethyl-N-nitrosourea-Induced Mouse Mutant with Audiogenic Epilepsy
Elena G. Varlamova, Екатерина Борисова, Yuliya A. Evstratova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17104-17104
Open Access | Times Cited: 1
Elena G. Varlamova, Екатерина Борисова, Yuliya A. Evstratova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17104-17104
Open Access | Times Cited: 1
Single-locus and Haplotype Associations of GRIN2B Gene with Autism Spectrum Disorders and the Demographic and Clinical Characteristics of Patients in Guilan, Iran
Donya Pouyan Mehr, Niloofar Faraji, Sajjad Rezaei, et al.
Journal of Autism and Developmental Disorders (2022) Vol. 54, Iss. 2, pp. 607-614
Closed Access | Times Cited: 1
Donya Pouyan Mehr, Niloofar Faraji, Sajjad Rezaei, et al.
Journal of Autism and Developmental Disorders (2022) Vol. 54, Iss. 2, pp. 607-614
Closed Access | Times Cited: 1
Further evidence supporting the role of GTDC1 in glycine metabolism and neurodevelopmental disorders
María Clara Bonaglia, Edoardo Errichiello, Mauro Lecca, et al.
Research Square (Research Square) (2023)
Open Access
María Clara Bonaglia, Edoardo Errichiello, Mauro Lecca, et al.
Research Square (Research Square) (2023)
Open Access